journal
MENU ▼
Read by QxMD icon Read
search

Cardiovascular Revascularization Medicine: Including Molecular Interventions

journal
https://www.readbyqxmd.com/read/30228050/impact-and-outcomes-of-patients-with-congestive-heart-failure-complicating-non-st-segment-elevation-myocardial-infarction-results-from-a-nationally-representative-united-states-cohort
#1
Ahmed Subahi, Abdullah Abdullah, Ahmed S Yassin, Hossam Abubakar, Ashraf Abugroun, George Eigbire, Amr Salama, Abdul Wahab, Ayman Abulawi, Eyas Kanaan, Aamer Javed, Mahir Elder, Amir Kaki, Richard Alweis, Tamam Mohamad
INTRODUCTION: Congestive heart failure (CHF) is seen in up to 13-25% of patients with NSTEMI. Recent data describing the impact of congestive heart failure (CHF) on in-hospital outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) in the United States is limited. We sought to examine the in-hospital outcomes, and management of CHF in patients admitted to the hospital with NSTEMI. METHODS: National Inpatient Sample (NIS) database (2010-2014) was analyzed to identify patients with NSTEMI using ICD-9-CM codes...
September 13, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30217626/coronary-perfusion-pressure-and-left-ventricular-hemodynamics-as-predictors-of-cardiovascular-collapse-following-percutaneous-coronary-intervention
#2
Kyle D Buchanan, Paul Kolm, Micaela Iantorno, Deepakraj Gajanana, Toby Rogers, Jiaxiang Gai, Rebecca Torguson, Itsik Ben-Dor, William O Suddath, Lowell F Satler, Ron Waksman
BACKGROUND/PURPOSE: Appropriate patient selection for mechanical circulatory support following percutaneous coronary intervention (PCI) remains a challenge. This study aims to evaluate the role of coronary perfusion pressure and other left ventricular hemodynamics to predict cardiovascular collapse following PCI. METHODS/MATERIALS: We retrospectively analyzed all patients who underwent PCI for acute coronary syndrome (ACS) from 2003 to 2016. Coronary perfusion pressure was calculated for each patient and defined as the difference in mean arterial pressure and left ventricular end diastolic pressure (LVEDP)...
September 10, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30224311/safety-of-same-day-discharge-after-percutaneous-coronary-intervention-with-orbital-atherectomy
#3
Evan Shlofmitz, Allen Jeremias, Alec Goldberg, Thomas Pappas, Andrew Berke, George Petrossian, Theofanis Tsiamtsiouris, Andrew Lituchy, Michael Lee, Richard Shlofmitz
BACKGROUND: Severely calcified lesions present many challenges to percutaneous coronary intervention (PCI). Orbital atherectomy (OA) aids vessel preparation and treatment of severely calcified coronary lesions. Same-day discharge (SDD) after PCI has numerous advantages including cost savings and improved patient satisfaction. The aim of this study is to evaluate the safety of SDD among patients treated with OA in a real-world setting. METHODS: This was a single-center retrospective analysis of patients undergoing OA...
September 6, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30201480/percutaneous-versus-surgical-pulmonic-valve-implantation-for-right-ventricular-outflow-tract-dysfunction
#4
Tariq Enezate, Jad Omran, Deepak L Bhatt
BACKGROUND/PURPOSE: Percutaneous pulmonic valve implantation (PPVI) is an alternative treatment strategy to surgical pulmonic valve implantation (SPVI) for right ventricular outflow tract (RVOT) dysfunction. This study sought to compare outcomes of both treatment strategies. METHODS: The study population was extracted from the 2014 Nationwide Readmissions Database (NRD) using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for PPVI and SPVI...
September 3, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30197099/the-prostacyclin-analogue-iloprost-as-an-early-predictor-of-successful-revascularization-in-diabetic-patients-affected-by-critical-limb-ischemia-and-foot-ulcers
#5
Valentina Izzo, Marco Meloni, Laura Giurato, Luigi Uccioli
PURPOSE: The aim of this study is to evaluate the role of Iloprost as an early predictor of successful revascularization in patients affected by ischemic diabetic foot ulcers (DFUs). METHODS: Consecutive patients with ischemic DFUs with persistent low TcPO2 (<30mmHg) one day after a technical successful Percutaneous Transluminal Angioplasty (PTA) have been included. All patients underwent Iloprost infusion and TcPO2 has been recorded at days 3, 14 and 30. According to the TcPO2 reported at day 3, patients were divided into two groups: group A (patients with TcPO2 ≥30mmHg) and group B (patients with TcPO2 <30mmHg)...
August 31, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30197100/do-we-need-a-guide-for-left-main-stenting
#6
Jacques Koolen
No abstract text is available yet for this article.
August 29, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30196030/network-meta-analysis-of-percutaneous-intervention-based-revascularization-strategies-for-st-elevation-myocardial-infarction-and-concomitant-multi-vessel-disease
#7
Urooj Fatima, Safi U Khan, Olabisi Akanbi, Saket Girotra, Isaac Opoku-Asare
BACKGROUND: In patients with ST elevation myocardial infarction (STEMI) and concomitant multi-vessel disease (MVD), primary percutaneous coronary intervention (PCI) of the culprit vessel is the preferred reperfusion strategy. However, optimum timing of revascularization for non-culprit artery is unclear. In this Bayesian network meta-analysis (NMA), we compared different PCI-based revascularization strategies in STEMI patients with MVD. METHODS: 11 randomized controlled trials (RCTs) were selected using MEDLINE, EMBASE and CENTRAL (Inception to September 2017)...
August 28, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30217627/rotational-atherectomy-combined-with-drug-coated-balloons-for-in-stent-restenosis
#8
Matthew Allan, Dominic Vickers, Mark Pitney, Nigel Jepson
BACKGROUND: Refractory coronary in-stent restenosis remains a clinically relevant problem in interventional cardiology despite the use of drug coated balloon angioplasty and further drug eluting stent deployment. In this study, we investigated whether the novel approach of lesion debulking with rotational atherectomy prior to drug coated balloon angioplasty for challenging coronary in-stent restenosis is safe and effective. METHODS: Procedural and registry data was retrospectively analysed for 26 patients who underwent rotational atherectomy immediately followed by drug coated balloon angioplasty to 43 coronary in-stent restenosis lesions with mean follow up of 19 months...
August 25, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30201481/outcomes-after-atherectomy-treatment-of-severely-calcified-coronary-bifurcation-lesions-a-single-center-experience
#9
Jeffrey W Chambers, Charles Warner, Josh Cortez, Ann N Behrens, Dylan T Wrede, Brad J Martinsen
BACKGROUND: Coronary bifurcation and calcified lesions account for 15-20% and 6%-20% of percutaneous coronary interventions (PCI), respectively. Treatment of these lesions is associated with high periprocedural complication rates and unfavorable long-term clinical outcomes, including high rates of revascularization. This retrospective, single-center study evaluated the outcomes of atherectomy treatment for heavily calcified coronary bifurcation lesions. METHODS: Patients who underwent a coronary atherectomy procedure to treat a heavily calcified lesion between January 2010 and March 2016 at Metropolitan Heart and Vascular Institute (Minneapolis, MN) were included in this retrospective study...
August 23, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30146231/stentless-strategy-in-primary-pci-setting-an-alternative-strategy-in-some-clinical-scenarios
#10
Kazuhiro Dan, Hector M Garcia-Garcia, Akira Shinoda, Ron Waksman
We described a case of successful stentless percutaneous coronary intervention (PCI) with Thrombolysis in Myocardial Infarction (TIMI) 3 flow in the right coronary artery (RCA) with diffuse large thrombus, and an algorithm of PCI strategy for the cases with similar clinical scenarios in the current PCI era. Theoretically, stentless PCI might be superior to PCI using a stent since it may prevent long-term issues of dual antiplatelet therapy, stent fracture, and stent thrombosis. In particular acute coronary syndrome with diffuse large thrombus in the RCA will make multiple stenting necessary which may be associated with worse outcomes due to distal coronary flow disorder...
August 23, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30232022/association-of-high-level-of-hs-crp-with-in-stent-restenosis-a-case-control-study
#11
Mojtaba Baktashian, Sara Saffar Soflaei, Negin Kosari, Mansoor Salehi, Alireza Khosravi, Maliheh Ahmadinejad, Mohsen Moohebati, Mahmood Ebrahimi, Farzad Rahmani, Ramin Khameneh-Bagheri, Mostafa Ahmadi, Fatemeh Sadabadi, Maryam Tayefi, Suzan Bazhdanzadeh, Gordon A Ferns, Seyed Mohammad Hashemi, Alireza Pasdar, Majid Ghayour-Mobarhan
BACKGROUND: In-stent restenosis (ISR) is one adverse outcome of coronary stent implantation. Although using drug-eluting stents has reduced the rate of ISR, it remains a major problem. Here, we have investigated the relationship between several patient characteristics including serum high sensitive C-reactive protein (hs-CRP) and ISR. METHODS: This was a case-control study comprising 104 individuals with ISR and 202 patients without. Baseline characteristics were collected using a questionnaire...
August 18, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30135042/antegrade-fenestration-and-re-entry-for-bailout-treatment-of-iatrogenic-coronary-dissection
#12
Pierluigi Merella, Giovanni Lorenzoni, Gabriele Luigi Gasparini, Jacopo Andrea Oreglia, Gavino Casu
No abstract text is available yet for this article.
August 17, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30177272/ischemic-evaluation-in-patients-presenting-with-hypertensive-emergency-urgency-and-acute-systolic-heart-failure-is-coronary-angiography-required-for-all
#13
Jared W Davis, Muhannad Almubarak, Amrita Mukherjee, Samuel K McElwee, Massoud A Leesar, Arka Chatterjee
BACKGROUND: Patients presenting with hypertensive urgency / emergency (HUE) often have systolic heart failure(SHF). Coronary angiography is routinely done for these patients to rule out obstructive coronary artery disease (Obs-CAD). We performed a retrospective study to investigate predictors of ObsCAD in this population. METHODS: Patients who underwent angiography to investigate SHF and had hospital admission(s) for HUE in the preceding 6 months were included in the study...
August 16, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30170829/simultaneous-thoracic-aortic-endovascular-graft-and-transfemoral-transcatheter-aortic-valve-replacement-in-a-patient-with-a-descending-aortic-thrombus
#14
Puja B Parikh, Shang Loh, Luis Gruberg, Jonathan Weinstein, Henry Tannous, Thomas Bilfinger
Severe descending thoracic and abdominal aortic pathology can deter consideration of transfemoral (TF) access for transcatheter aortic valve replacement (TAVR) in adults with severe symptomatic aortic stenosis (AS) and may lead to utilization of alternative access sites. We report a case of an 88-year-old frail woman with severe symptomatic AS referred for TAVR with demonstration of a large thrombus in the descending thoracic aorta immediately distal to the left subclavian artery. Given concerns of thrombus embolization with femoral advancement of the transcatheter valve, coverage with a thoracic aortic endograft was planned immediately prior to the TAVR...
August 16, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30170828/a-randomised-trial-comparing-two-stent-sizing-strategies-in-coronary-bifurcation-treatment-with-bioresorbable-vascular-scaffolds-the-absorb-bifurcation-coronary-abc-trial
#15
Rajiv Rampat, Thomas Mayo, David Hildick-Smith, James Cockburn
BACKGROUND: Limited information is available on the use of Bioresorbable Vascular Scaffold (BVS) in bifurcations involving significant side branches. When treating bifurcation disease with metal stents, the recommendation is to choose a stent diameter based on the distal main vessel diameter. Whether this sizing strategy is applicable to BVS is currently unknown. METHODS: We randomised 37 patients undergoing elective PCI for 'false' bifurcation disease (Medina 0,1,0; 1,0,0; 1,1,0) to receive BVS based either on proximal or distal reference diameters...
August 16, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30126824/drug-eluting-balloons-versus-everolimus-eluting-stents-for-in-stent-restenosis-a-meta-analysis-of-randomized-trials
#16
Islam Y Elgendy, Ahmed N Mahmoud, Akram Y Elgendy, Mohammad K Mojadidi, Ayman Elbadawi, Parham Eshtehardi, María José Pérez-Vizcayno, Siddharth A Wayangankar, Hani Jneid, R David Anderson, Fernando Alfonso
OBJECTIVES: Individual randomized trials comparing drug-eluting balloons (DEB) versus everolimus-eluting stents (EES) for in-stent restenosis (ISR) were underpowered for clinical end-points. The objective of this study was to compare the clinical outcomes of DEB versus EES for any ISR. MATERIALS & METHODS: Electronic databases were searched for randomized trials which compared DEB versus EES for any ISR (i.e., drug eluting or bare metal stents). Summary estimate risk ratios (RRs) were constructed using a DerSimonian and Laird random effects model...
August 16, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30121221/an-uncommon-but-important-cause-of-stent-thrombosis-kounis-syndrome
#17
Sho Torii, Renu Virmani, Aloke Finn
No abstract text is available yet for this article.
August 14, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30121218/closure-of-the-patent-foramen-ovale-stepping-out-of-the-cinderella-role
#18
Bernhard Meier, Fabian Nietlispach
No abstract text is available yet for this article.
August 14, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30121217/the-influence-of-gender-on-in-hospital-clinical-outcome-following-isolated-mitral-or-aortic-heart-valve-surgery
#19
S Chiu Wong, Ilhwan Yeo, Geoffrey Bergman, Dmitriy N Feldman, Harsimran Singh, Robert Minutello, Luke K Kim
BACKGROUND: With the expected growth in the elderly segment of the U.S. population particularly in women, the prevalence of valvular heart disease is bound to increase in the coming years. We sought to delineate the impact of gender on in-hospital clinical outcomes in Medicare-age patients undergoing isolated left-side heart valve surgery. METHODS: Using the National Inpatient Sample files from 2003 to 2014, we compared the in-hospital major adverse cardiac and cerebral events (MACCE: all-cause mortality, stroke, or myocardial infarction) and composite complications (MACCE, permanent pacemaker implantation, bleeding requiring transfusion, iatrogenic vascular complications, acute respiratory failure, acute kidney injury requiring hemodialysis, sepsis and prolonged hospital stay) following isolated mitral or aortic surgery between genders with 1:1 propensity score analysis...
August 10, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/30100407/use-of-the-ocelot-catheter-in-iliac-chronic-total-occlusion-intervention
#20
Nachiket J Patel, Ajay U Mhatre, Richard R Heuser
No abstract text is available yet for this article.
August 9, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
journal
journal
40959
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"